Connor Meehan

Connor Meehan is an Analyst at Redmile Group in New York, NY, where he focuses on sourcing, evaluating, and executing investments primarily in the healthcare, medtech, and life sciences sectors. In his current capacity, Meehan conducts extensive market and financial analysis to support the firm’s investment strategy, leveraging deep sectoral insights to identify high-potential opportunities within innovative healthcare companies.

Prior to joining Redmile Group in August 2021, Connor served as an Equity Research Senior Associate and Equity Research Associate at Morgan Stanley, where he gained notable experience in financial modeling, sector analysis, and investment recommendation processes for public equities. His professional background demonstrates a strong grounding in both fundamental company research and actionable investment insight within complex, high-growth industries.

Connor holds a Bachelor of Science in Business Administration with a concentration in Finance and a minor in Biology from Northeastern University, reflecting a unique blend of financial acumen and scientific literacy. This multidisciplinary expertise underpins his contributions in evaluating investment opportunities in emerging healthcare technologies and biopharma assets.